Home/Stocks/Consumer Cyclicals

Currys PLC

CURY.L·Consumer Cyclicals·Market Cap £1.6b
Rank #82 of 280
Quantitative Model · 280 Stocks Analysed
£1.47
+16.59% YTD
52W: £1.17 - £1.70

Factor Analysis Summary

Editorial assessment generated from Currys PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Currys PLC (CURY.L) currently holds an overall rank of #82 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively, and valuation (P/E 10.6, dividend yield 6.8%), where it demonstrates reasonable valuation with several price-based metrics ranking favourably.

Areas requiring attention include market trading, where low relative volume or adverse volatility patterns may deter momentum-oriented investors, as well as profitability (ROE 7.1%, net margin 1.8%), where compressed margins and weak returns on equity weigh on the earnings profile.

Within the Consumer Cyclicals sector, Currys PLC sits at composite rank #82, trailing the Consumer Cyclicals peer average (rank 44). It ranks behind all 6 tracked Consumer Cyclicals peers in our model.

The composite profile is weighed down by 5 below-average factor scores, with market trading (rank 255/280) representing the most significant drag on its #82 overall standing.

Strongest Factors

  • Asset Efficiency — Rank 24/280 (top quartile)
  • Valuation — Rank 89/280 (above average)
  • Solvency — Rank 206/280 (below average)

Weakest Factors

  • Market Trading — Rank 255/280 (below average)
  • Profitability — Rank 246/280 (below average)

Score Analysis

Currys PLC is ranked #82 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

183/280
Average Score
Liquidity
Weak232/280
Valuation
Good89/280
Profitability
Weak246/280
Solvency
Weak206/280
Asset Efficiency
Excellent24/280
Mkt Trading
Weak255/280
Technical
Weak226/280

1. Liquidity

Score: 232/280

How liquid is CURY and can it meet its short-term obligations?

0/6
liquidity criteria met
✗
Quick Ratio0.38x
Range: 0.7 - 1.2Rank 140/280
✗
Current Ratio0.89x
Range: 1.2 - 1.8Rank 178/280
✗
TTM Operating Cash Flow0.16x
Range: 0.8 - 1.2Rank 197/280
–
Liquidity Coverage RatioN/A
Range: N/A
✗
Intangible Asset Ratio0.03x
Range: 3 - 15Rank 120/280
✗
Cash-to-Debt Ratio0.15x
Range: 0.3 - 0.8Rank 175/280

Key Liquidity Metrics

Quick Ratio
0.38x
Sector: 0.7 - 1.2
Current Ratio
0.89x
Sector: 1.2 - 1.8

Overall Liquidity Rank

Rank within universe#232/280
Best (1)Worst (280)

2. Valuation

Score: 89/280

Is CURY undervalued compared to its peers and fair value metrics?

1/7
valuation criteria met
✗
FY27e P/E9.6x
Range: 12x - 30xRank 51/280
✗
FY26e P/E10.7x
Range: 12x - 30xRank 53/280
✓
FY27e Net Div Yld (%)2.29%
Range: 1.0 - 4.0Rank 165/280
✗
Div Payout Ratio20.00%
Range: 25 - 50Rank 50/280
✗
Current EV/EBITDA4.0x
Range: 7.0x - 11.0xRank 35/280
–
Current P/TBVN/A
Range: 1.5x - 4.5x
✗
Current P/B0.58x
Range: 1.5x - 4.5xRank 8/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
10.6x
FY26e P/E
Forward estimate
10.7x
FY27e P/E
Forward estimate
9.6x
Current P/B
Price-to-Book
0.58x
Current P/TBV
Tangible Book Value
N/A
Current EV/EBITDA
Enterprise Value
4.0x
FY26e EV/EBITDA
Forward estimate
4.4x
FY27e EV/EBITDA
Forward estimate
4.4x

Dividend

CURY pays a dividend yield of 6.82%.

Current Yield
6.82%
FY27e Net Div Yield
2.29%
FY26e Gross DPS
0.026
FY27e Gross DPS
0.034

Dividend Per Share Forecast

3. Profitability

Score: 246/280

How profitable is CURY relative to its peers?

1/7
profitability criteria met
✗
TTM Profit Margin1.8%
Range: 3 - 8Rank 236/280
✗
T12 FCF Margin0.2%
Range: 3 - 10Rank 136/280
✓
FY27e RoE6.0%
Range: 5 - 12Rank 183/280
✗
FY26 EPS Growth8.5%
Range: 0 - 5Rank 108/280
✗
FY27e EPS Growth19.9%
Range: 5 - 12Rank 111/280
–
NIMN/A
Range: N/A
–
Expense RatioN/A
Range: 85 - 92
TTM Profit Margin
1.8%
Current RoCE
7.1%
FY27e RoE
6.0%
T12 FCF Margin
0.2%

EPS Growth

4. Solvency

Score: 206/280

How strong is CURY's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.40x
Range: 0.5x - 1.2xRank 122/280
–
Interest Coverage RatioRank 182
Range: 3x - 8xRank 182/280
✗
Net Leverage Ratio1.45x
Range: 1.5x - 3.5xRank 101/280
–
Altman Z-Score (Manufacturing)0.62
Range: <1.10 - >2.60Rank 230/280
–
Z-Score (Non Manufacturing)Rank 181
Range: <1.10 - >2.60Rank 181/280
–
CapAdeq Ratio Tier1N/A
Range: N/A

Key Solvency Metrics

Debt/Eqt
0.40x
Net Leverage Ratio
1.45x
Interest Coverage
Rank 182
T12 FCF Margin
0.2%

Altman Z-Score

0.62
Distress Zone
01.812.995+

5. Asset Efficiency

Score: 24/280

How efficiently does CURY deploy its assets and intellectual capital?

1/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: N/A
✓
TTM Asset Turnover Ratio1.67x
Range: 1.0x - 2.5xRank 20/280
✗
TTM CAPEX/Sales0.9%
Range: 3 - 8Rank 180/280
–
Working Capital TurnoverN/A
Range: 5x - 12x
–
R&D/Sales FY27eN/A
Range: 0.5 - 3.0

Overall Asset Efficiency Rank

Rank within sector peers#24/280
Best (1)Worst (280)

6. Market Trading

Score: 255/280

How liquid and actively traded is CURY?

2/2
market trading criteria met
✓
Intraday Sentiment (%)70.0%
Range: 30 - 70Rank 64/280
–
10D-Avg v/s 3M-Avg Vol47%
Range: N/ARank 100/280
✓
Avg Directional Index 30D21.3
Range: 012 - 45Rank 121/280
–
Parabolic SAR143.80
Range: N/ARank 252/280
–
Stock Rating RankRank 100
Range: N/ARank 100/280
Market Cap
£1,586,248,295
Enterprise Value
£2,392,087,802

Trading Volume

7. Technical

Score: 226/280

What do the technical indicators say about CURY?

0/5
technical criteria met
–
CMP v/s 52-WH-13.3%
£1.70£1.17
-13.3%CMP: £1.47
Range: N/ARank 156/280
–
CMP v/s 52-WL25.9%
£1.70£1.17
+25.9%CMP: £1.47
Range: N/ARank 149/280
–
RSI 14D52.8
052.8 - Bullish100
Range: N/ARank 50/280
–
MA50 - MA200Bullish
£1.46+0.06£1.52
Range: N/ARank 177/280
–
MACD Rank0.34
Golden Cross
MACD: 0.34
Range: N/ARank 100/280

RSI (14 Day)

52.8
Bullish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£1.52
200 SMA£1.46
SignalGolden Cross (Bullish)
MACD0.34

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does CURY compare to other Consumer Cyclicals stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
CURY#8223289246206255226
GAW.L#109267933618240
NXT.L#224026194105233
FOUR.L#31135202184248212
GFTU_u.L#564914521812515311
MOONM.L#70144178158161135116
CPG.L#72156203150129266215
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Currys PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.